Comparison of the efficacyof PRP injection alone and combination of PRP and SVF injection in the treatment of androgenetic alopecia

Phase 2

Recruiting

Conditions: Androgenetic alopecia.
Androgenic alopecia

Registration Number: IRCT20210414050963N1

Lead Sponsor: Skin and Stem Cell Research Center

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 24

Inclusion Criteria

Ladies and gentlemen with androgenetic alopecia
Age 18 years and above and less than 50 years old
Hamilton score 2 to 5 in men
Ludwig score 1 to 3 in women
Complete patient consent to participate in the project

Exclusion Criteria

Platelet dysfunction
Thrombocytopenia
Anticoagulant drug use
Malignancy
Chemotherapy within 5 years
Sepsis
Smoking
Pregnancy
Ulcer or infection at the site of treatment
Do not receive any topical or systemic medication in the last 3 months
Women with hyperprolactinemia
Women with hormonal dysfunction or polycystic ovarian disease

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Alopecia severity. Timepoint: Before start of the trial and two months after the last session. Method of measurement: Rate of change in the clinical severity of alopecia is measured by imaging with visioface. hamilton scale 1 to 6 in men.Ludwig scale 1 to 3 in women.;The amount of hair in the telogen phase. Timepoint: Before the beginning of the trial and two months after the last session. Method of measurement: The amount of hair in the telogen phase is measured by pull test.;Hair density. Timepoint: Before the beginning of the trial and two months after the last session. Method of measurement: Hair density is measured by trichoscan.;Patient satisfaction of treatment. Timepoint: Two months after the last session of treatment. Method of measurement: Patient global assessment score.;Physician satisfaction of treatment. Timepoint: Two months after the last session of treatment. Method of measurement: Physician global assessment score.

Secondary Outcome Measures